Compare · INLF vs TMO
INLF vs TMO
Side-by-side comparison of INLIF LIMITED (INLF) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INLF and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.71B, about 405657.6x INLF ($635,299).
- Both names hit the wire about 6 times in the past 4 weeks.
- TMO has more recent analyst coverage (25 ratings vs 0 for INLF).
- Company
- INLIF LIMITED
- Thermo Fisher Scientific Inc
- Price
- $0.31+7.50%
- $697.69+2.19%
- Market cap
- $635,299
- $257.71B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 6
- 6
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest INLF
- SEC Form SCHEDULE 13G filed by INLIF LIMITED
- SEC Form 6-K filed by INLIF LIMITED
- SEC Form SCHEDULE 13G filed by INLIF LIMITED
- INLIF LIMITED Announces Closing of US$3.75 Million Registered Direct Offering
- SEC Form 424B5 filed by INLIF LIMITED
- INLIF LIMITED Announces Pricing of $3.75 Million Registered Direct Offering
- SEC Form 6-K filed by INLIF LIMITED
- SEC Form 6-K filed by INLIF LIMITED
- SEC Form 6-K filed by INLIF LIMITED
- INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results
Latest TMO
- Director Sperling Scott M gifted 3,490 shares, decreasing direct ownership by 5% to 65,989 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Reports Third Quarter 2026 Results
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M